5/15
12:25 pm
jspr
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $65.00 price target on the stock.
Low
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $65.00 price target on the stock.
5/6
08:05 am
jspr
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $65.00 price target on the stock.
High
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $65.00 price target on the stock.
4/3
08:07 am
jspr
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $65.00 price target on the stock.
Low
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $65.00 price target on the stock.
4/3
08:07 am
jspr
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $65.00 price target on the stock.
Low
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $65.00 price target on the stock.
4/3
07:32 am
jspr
Rating for JSPR
Medium
Report
Rating for JSPR
4/3
06:40 am
jspr
Jasper Therapeutics initiated with bullish view at Evercore ISI
Low
Report
Jasper Therapeutics initiated with bullish view at Evercore ISI
4/3
06:40 am
jspr
Jasper Therapeutics initiated with bullish view at Evercore ISI
Low
Report
Jasper Therapeutics initiated with bullish view at Evercore ISI
3/28
08:07 am
jspr
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $70.00 price target on the stock.
Low
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $70.00 price target on the stock.
3/28
08:07 am
jspr
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $70.00 price target on the stock.
Low
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $70.00 price target on the stock.
3/28
04:35 am
jspr
Rating for JSPR
Low
Report
Rating for JSPR
3/28
04:35 am
jspr
Rating for JSPR
Low
Report
Rating for JSPR
3/7
08:25 am
jspr
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $80.00 price target on the stock.
Low
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $80.00 price target on the stock.
3/7
08:01 am
jspr
Rating for JSPR
Low
Report
Rating for JSPR
3/7
08:01 am
jspr
Rating for JSPR
Low
Report
Rating for JSPR